Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Pozzilli

Showing results (221-230 of 225) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 225 results.
JAMA|January 4, 2018
Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial, Mikael Knip, Hans K Åkerblom, et al.
Lancet (London, England)|April 9, 2013
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trialsAntoinette Moran, Brian Bundy, Dorothy J Becker, et al.
Journal of Cardiovascular Pharmacology|July 22, 2025
Perspectives on artificial intelligence in medical publishing: a survey of medical journal editorsGiuseppe Biondi-Zoccai, Attilio Lauretti, Stefan Agewall, et al.
Diabetes Care|July 28, 2012
Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studiesChris R Cardwell, Lars C Stene, Johnny Ludvigsson, et al.
The New England Journal of Medicine|February 3, 2012
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitusJohnny Ludvigsson, David Krisky, Rosaura Casas, et al.
Pageof 23

Showing results (221-230 of 225) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 225 results.
JAMA|January 4, 2018
Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial, Mikael Knip, Hans K Åkerblom, et al.
Lancet (London, England)|April 9, 2013
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trialsAntoinette Moran, Brian Bundy, Dorothy J Becker, et al.
Journal of Cardiovascular Pharmacology|July 22, 2025
Perspectives on artificial intelligence in medical publishing: a survey of medical journal editorsGiuseppe Biondi-Zoccai, Attilio Lauretti, Stefan Agewall, et al.
Diabetes Care|July 28, 2012
Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studiesChris R Cardwell, Lars C Stene, Johnny Ludvigsson, et al.
The New England Journal of Medicine|February 3, 2012
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitusJohnny Ludvigsson, David Krisky, Rosaura Casas, et al.
Pageof 23